PPAT and liver cancer: They reported higher activity of glutamine PRPP amidotransferase enzyme (GPAT; EC 2.4.2.14), an enzyme regulating synthesis of inosine monophosphate (IMP) in liver cancer cells, with significantly lower IMP degradation.